Fig. 3From: Clinical effects, cardiovascular and renal outcomes associated with rapid-acting insulin analogs among individuals with type 2 diabetes: a nation-wide observational cohort studyAverage weight during follow-up period among patients treated with lispro, aspart, and glulisineBack to article page